+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

Thyroid Cancer Drugs Market Report 2026 - Product Thumbnail Image

Thyroid Cancer Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Acute Pancreatitis Market Report 2026 - Product Thumbnail Image

Acute Pancreatitis Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Intestinal Pseudo-Obstruction Treatment Market Report 2026 - Product Thumbnail Image

Intestinal Pseudo-Obstruction Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Gastroesophageal Reflux Disease (GERD) Market Report 2026 - Product Thumbnail Image

Gastroesophageal Reflux Disease (GERD) Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Lupus Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Lupus Therapeutics - Global Strategic Business Report

  • Report
  • August 2026
  • 260 Pages
  • Global
From
Psoriatic Arthritis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Psoriatic Arthritis Therapeutics - Global Strategic Business Report

  • Report
  • August 2026
  • 276 Pages
  • Global
From
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 1560 Pages
  • Global
From
Multiple Myeloma (Kahler Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Multiple Myeloma (Kahler Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 1182 Pages
  • Global
From
U.S. Orphan Drug Market, Drug Sales, Price, Dosage & Clinical Pipeline Insight 2031 - Product Thumbnail Image

U.S. Orphan Drug Market, Drug Sales, Price, Dosage & Clinical Pipeline Insight 2031

  • Drug Pipelines
  • February 2026
  • 3300 Pages
  • United States
From
Drug and Gene Delivery Devices - Global Strategic Business Report - Product Thumbnail Image

Drug and Gene Delivery Devices - Global Strategic Business Report

  • Report
  • August 2026
  • 278 Pages
  • Global
From
Paresthesia Treatment Market - Global Strategic Business Report - Product Thumbnail Image

Paresthesia Treatment Market - Global Strategic Business Report

  • Report
  • August 2026
  • 381 Pages
  • Global
From
Celiac Diseases Drugs - Global Strategic Business Report - Product Thumbnail Image

Celiac Diseases Drugs - Global Strategic Business Report

  • Report
  • August 2026
  • 367 Pages
  • Global
From
Ulcerative Colitis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Ulcerative Colitis Therapeutics - Global Strategic Business Report

  • Report
  • August 2026
  • 208 Pages
  • Global
From
Inflammatory Bowel Disease (IBD) Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Inflammatory Bowel Disease (IBD) Therapeutics - Global Strategic Business Report

  • Report
  • August 2026
  • 504 Pages
  • Global
From
KRAS Inhibitors Market, Drug Sales, Patent, Price & Clinical Trials Insight 2030 - Product Thumbnail Image

KRAS Inhibitors Market, Drug Sales, Patent, Price & Clinical Trials Insight 2030

  • Report
  • April 2025
  • 240 Pages
  • Global
From
Acute Ischemic Stroke Therapeutics Market 2026-2030 - Product Thumbnail Image

Acute Ischemic Stroke Therapeutics Market 2026-2030

  • Report
  • January 2026
  • 291 Pages
  • Global
From
Wearable Injectors - Global Strategic Business Report - Product Thumbnail Image

Wearable Injectors - Global Strategic Business Report

  • Report
  • August 2026
  • 179 Pages
  • Global
From
Chronic Lymphocytic Leukemia (CLL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Chronic Lymphocytic Leukemia (CLL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 628 Pages
  • Global
From
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 820 Pages
  • Global
From
Non-Viral / Intracellular Drug Delivery Systems Market by Type of Molecule, Type of Biologics Delivered, Type of Vehicle Used, Type of Therapeutic Area, Type of Payments and Key Geographies: Industry Trends and Global Forecasts, 2023-2035 - Product Thumbnail Image

Non-Viral / Intracellular Drug Delivery Systems Market by Type of Molecule, Type of Biologics Delivered, Type of Vehicle Used, Type of Therapeutic Area, Type of Payments and Key Geographies: Industry Trends and Global Forecasts, 2023-2035

  • Report
  • January 2023
  • 270 Pages
  • Global
From
Loading Indicator